Sodium-glucose co-transporter 2 inhibitor add-on therapy for metformin delays diabetic retinopathy progression in diabetes patients: a population-based cohort study

To investigate how sodium-glucose co-transporter 2 inhibitors (SGLT2is) add-on therapy for metformin affects diabetic retinopathy (DR) progression in patients with type 2 diabetes mellitus (T2DM). This nationwide population-based study conducted from January 1, 2016, to December 31, 2018 involved 3,...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jing-Xing, Hung, Yu-Tung, Bair, Henry, Hsu, Shu-Bai, Hsu, Chung-Yi, Lin, Chun-Ju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10564914/
https://www.ncbi.nlm.nih.gov/pubmed/37816862
http://dx.doi.org/10.1038/s41598-023-43893-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10564914/
https://www.ncbi.nlm.nih.gov/pubmed/37816862
http://dx.doi.org/10.1038/s41598-023-43893-2

Ejemplares similares